Actionable news
0
All posts from Actionable news
Actionable news in KITE: KITE PHARMA Inc,

Kite Pharma, Inc.'s SVP Clinical Development just cashed-in 9,000 options

Jeffrey Wiezorek, Kite Pharma, Inc.'s SVP Clinical Development, recently cashed-in 9,000 options. The options were exercised at $6.89, while the disposals took place between $60.42 and $64.19 per share, on October 15, 2015. Wiezorek continues to hold 6,342 shares of the company. Wiezorek operates out of Santa Monica, CA. Some additional info was provided as follows:

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.97 to $60.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of t he Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple...

More